Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 5/20 | 0.90 |
| ▸ | PPARG | P37231 | 4/20 | 0.82 |
| ▸ | CTSS | P25774 | 3/20 | 0.72 |
| ▸ | KLK7 | P49862 | 2/20 | 0.60 |
| ▸ | KLK5 | Q9Y337 | 2/20 | 0.60 |
| ▸ | ACE | P12821 | 1/20 | 0.58 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.57 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.55 |
| ▸ | CDC25B | P30305 | 4/20 | 0.55 |
| ▸ | PTPN2 | P17706 | 3/20 | 0.55 |
| ▸ | CDC25A | P30304 | 2/20 | 0.55 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.55 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | CTSL | P07711 | 1/20 | 0.54 |
| ▸ | CTSB | P07858 | 1/20 | 0.54 |
| ▸ | CTSK | P43235 | 1/20 | 0.54 |
| ▸ | PPARD | Q03181 | 2/20 | 0.54 |
| ▸ | MME | P08473 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1132901 | 1.00 | PPARA (0.90) | PPARAPPARGCTSSKLK7KLK5 | |
| SCHEMBL828674 | 1.00 | PPARA (0.90) | PPARAPPARGCTSSKLK7KLK5 | |
| SCHEMBL20899650 | 0.95 | PPARA (0.82) | PPARAPPARGCTSSKLK7KLK5 | |
| SCHEMBL12130757 | 0.94 | PPARA (0.85) | PPARAPPARGCTSSKLK7KLK5 | |
| SCHEMBL18555201 | 0.92 | PPARA (0.78) | PPARAPPARGCTSSKLK7KLK5 | |
| SCHEMBL18555200 | 0.92 | PPARA (0.78) | PPARAPPARGCTSSKLK7KLK5 | |
| SCHEMBL3820032 | 0.91 | PPARA (0.76) | PPARAPPARGCTSSKLK7KLK5 | |
| SCHEMBL29229102 | 0.91 | PPARA (0.76) | PPARAPPARGCTSSKLK7KLK5 | |
| SCHEMBL7057256 | 0.91 | PPARA (0.76) | PPARAPPARGCTSSKLK7KLK5 | |
| SCHEMBL29556874 | 0.90 | PPARA (0.75) | PPARAPPARGCTSSKLK7KLK5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 657 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119528812-B | Double amino acid-genipin derivative and preparation method and application thereof | 广东工业大学 | 2025-06-03 | — | — | CN | claimed |
| CN-119528812-A | Double amino acid-genipin derivative and preparation method and application thereof | 广东工业大学 | 2025-02-28 | — | — | CN | claimed |
| CN-118119631-A | Programmable selective acylation of polyols | 南洋理工大学 | 2024-05-31 | — | — | CN | claimed |
| CN-111825742-B | Polypeptide solid phase synthesis of CTPA as special coupling agent for amino acid ionic liquid | 陈铭 | 2024-01-30 | — | — | CN | claimed |
| CN-116874803-A | Antibacterial dendritic polyester polymer and preparation method and application thereof | 清华大学深圳国际研究生院 | 2023-10-13 | — | — | CN | claimed |
| CN-113956183-B | Boc-Ser (Bzl) -OH and preparation method thereof | 成都市科隆化学品有限公司 | 2023-06-20 | — | — | CN | claimed |
| CN-115477648-A | Carboline derivative, preparation method thereof and application thereof in preparing antitumor drugs | 首都医科大学 | 2022-12-16 | — | — | CN | claimed |
| EP-3988538-A1 | MODIFIED HYDROPHOBIC AUXILIARY MATERIAL, PREPARATION METHOD THEREFOR AND USE THEREOF | Zhejiang Zhida Pharmaceutical Co., Ltd. (CN) | 2022-04-27 | — | — | EP | claimed |
| US-20220111055-A1 | MODIFIED HYDROPHOBIC EXCIPIENT AND PREPARATION METHOD THEREOF | ZHEJIANG ZHIDA PHARMACEUTICAL CO., LTD. (CN) | 2022-04-14 | — | — | US | claimed |
| CN-113956183-A | Boc-Ser (Bzl) -OH and preparation method thereof | 成都市科隆化学品有限公司 | 2022-01-21 | — | — | CN | claimed |
| EP-0357750-B1 | URETHANE-PROTECTED AMINO ACID-N-CARBOXYANHYDRIDES | BIORESEARCH INC (US) | 1994-07-13 | — | — | EP | claimed |
| JP-61010598-A | — | — | None | — | — | JP | disclosed |
| JP-60161999-A | — | — | None | — | — | JP | disclosed |
| JP-63190900-A | — | — | None | — | — | JP | disclosed |
| US-12616676-B2 | Preparation method and use of modified hydrophobic excipient | ZHEJIANG ZHIDA PHARMACEUTICAL CO., LTD. (CN) | 2026-05-05 | — | — | US | disclosed |
| US-4028315-A | Solid phase synthesis of peptides | E. R. SQUIBB & SONS, INC. (US) | 1977-06-07 | — | — | US | disclosed |
| US-4000259-A | DIABETES | AMERICAN HOME PRODUCTS CORPORATION (US) | 1976-12-28 | — | — | US | disclosed |
| US-3992530-A | [D-2-(1,4-Cyclohexadienyl)gly]6 -des-gly10 -lrh nonapeptide amides | AMERICAN HOME PRODUCTS CORPORATION (US) | 1976-11-16 | — | — | US | disclosed |
| US-3974135-A | Synthetic decapeptide having the activity of the luteinizing hormone releasing hormone and method for producing the same | FOLKERS KARL | 1976-08-10 | — | — | US | disclosed |
| US-3953416-A | Synthetic decapeptide having the activity of the luteinizing hormone releasing hormone and method for manufacturing the same | FOLKERS KARL | 1976-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12616676-B2 | Preparation method and use of modified hydrophobic excipient | CETP, LIPA, MTTP | PPARA 1878/4885PPARG 853/4885CTSS 2330/4885 |
| US-20220111055-A1 | MODIFIED HYDROPHOBIC EXCIPIENT AND PREPARATION METHOD THEREOF | CETP, SLC43A1, SLC27A1 | PPARA 1752/4885PPARG 2783/4885CTSS 3839/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.